Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000726566 | SCV000235833 | benign | not provided | 2020-03-26 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726566 | SCV000345579 | uncertain significance | not provided | 2016-09-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084984 | SCV000625880 | benign | Duchenne muscular dystrophy | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000183385 | SCV001433373 | likely benign | not specified | 2019-04-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002433814 | SCV002747704 | likely benign | Cardiovascular phenotype | 2018-10-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001826925 | SCV002089668 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-06-24 | no assertion criteria provided | clinical testing |